Aura Biosciences, Inc. (AURA)

NASDAQ: AURA · IEX Real-Time Price · USD
17.02
-0.64 (-3.62%)
May 20, 2022 4:00 PM EDT - Market closed

Ratios and Metrics (Trailing)

Millions USD. Fiscal year is Jan - Dec.
Period EndedCurrent2022-03-312021-12-31
Market Capitalization
498643496
Enterprise Value
366510348
PE Ratio
---10.74
PB Ratio
3.534.563.26
Debt / Equity Ratio
0.010.010.01
Debt / EBITDA Ratio
---0.03
Debt / FCF Ratio
---0.03
Current Ratio
27.9027.9021.14
Return on Equity (ROE)
---211.90%
Return on Assets (ROA)
---50.70%
Return on Capital (ROIC)
---1055.70%
Earnings Yield
-10.20%--9.31%
FCF Yield
---6.96%
Buyback Yield / Dilution
---1305.21%
Total Shareholder Return
-0.00%-1305.21%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).